Skip to main content
. 2011 Nov 3;105(Suppl 1):S5–S10. doi: 10.1038/bjc.2011.417

Figure 3.

Figure 3

(A) Women newly diagnosed, living with breast cancer by year since diagnosis and breast cancer deaths, UK, 2008.a,b (B) People newly diagnosed, living with colorectal cancer by year since diagnosis and colorectal cancer deaths, UK, 2008.a,b (C) People newly diagnosed, living with lung cancer by year since diagnosis and lung cancer deaths, UK, 2008.a,b aFemale breast (ICD-10 C50). Colon, rectum and anus (ICD-10 C18-C21). Lung, bronchus and trachea (ICD-10 C33-C34). bIncidence is the number of newly diagnosed cases and is a count of tumours in 2008. Mortality is a count of deaths due to cancer in 2008. Prevalence is a count of the number of people living with cancer at the end of 2008. cPrevalence measures time since diagnosis up to 1, 5, 10 or 20 years. For example, ‘1⩾5 years’ means more than 1 year and up to 5 years since diagnosis and ‘>20 years’ is more than 20 years since diagnosis. The prevalence estimate for men with lung cancer more than 20 years from diagnosis is likely be overestimated by ∼8000. Sources: Maddams et al (2009); Cancer Research UK (2010); Information Services Division (ISD) Scotland (2010); Northern Ireland Cancer Registry (2011); Welsh Cancer Intelligence and Surveillance Unit (2010); Office for National Statistics (2010a, 2010b).